PAPEL DE LAS FORMAS CORTA Y SOLUBLE DE ENDOGLINA EN LA HOMEOSTASIS VASCULAR
ENDOGLIN (CD105) IS AN INTEGRAL MEMBRANE GLYCOPROTEIN THAT SERVES AS CO-RECEPTOR FOR MEMBERS OF THE TRANSFORMING GROWTH FACTOR BETA (TGF-) SUPERFAMILY OF PROTEINS, A MAJOR ROLE FOR ENDOGLIN IN REGULATING TGF--DEPEN...
ver más
Financiación
concedida
El organismo AGENCIA ESTATAL DE INVESTIGACIÓN notifico la concesión del proyecto
el día 2010-01-01
No tenemos la información de la convocatoria
0%
100%
Información adicional privada
No hay información privada compartida para este proyecto. Habla con el coordinador.
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SAF2010-19222
ESTUDIOS MOLECULARES SOBRE ENDOGLINA Y ALK1, DOS COMPONENTES...
303K€
Cerrado
SAF2013-43421-R
ANALISIS DE UN NUEVO ROL DE ENDOGLINA EN ADHESION CELULAR Y...
303K€
Cerrado
SAF2015-74313-JIN
ANALISIS FUNCIONAL DE MIRNAS EXOSOMALES ASOCIADOS A LA TELAN...
205K€
Cerrado
PID2019-108902GB-I00
PAPEL DE LA TDP-43 EN LAS CELULAS ENDOTELIALES Y SU IMPORTAN...
121K€
Cerrado
SAF2013-42359-ERC
LA BASE MOLECULAR DE LA FUNCION DE NOTCH EN DIFERENTES CONTE...
75K€
Cerrado
SAF2013-45784-R
NUEVOS PAPELES FISIOLOGICOS Y PATOLOGICOS DE LAS ISOFORMAS D...
290K€
Cerrado
Descripción del proyecto
ENDOGLIN (CD105) IS AN INTEGRAL MEMBRANE GLYCOPROTEIN THAT SERVES AS CO-RECEPTOR FOR MEMBERS OF THE TRANSFORMING GROWTH FACTOR BETA (TGF-) SUPERFAMILY OF PROTEINS, A MAJOR ROLE FOR ENDOGLIN IN REGULATING TGF--DEPENDENT VASCULAR REMODELING AND ANGIOGENESIS HAS BEEN POSTULATED BASED ON: I) ENDOGLIN IS THE GENE MUTATED IN HEREDITARY HEMORRHAGIC TELANGIECTASIA (HHT) TYPE 1, A DISEASE CHARACTERIZED BY VASCULAR MALFORMATIONS; II) ENDOGLIN KNOCKOUT MICE DIE DURING THE EMBRYONARY PHASE DUE TO A DEFECTIVE ANGIOGENESIS; III) ENDOGLIN IS OVEREXPRESSED IN NEOANGIOGENIC VESSELS, DURING INFLAMMATION, AND IN SOLID TUMORS; AND IV) ENDOGLIN REGULATES THE EXPRESSION AND ACTIVITY OF ENDOTHELIAL NITRIC OXIDE SYNTHASE (ENOS), WHICH IS INVOLVED IN ANGIOGENESIS AND VASCULAR TONE, BESIDES THE PREDOMINANT FORM OF THE ENDOGLIN RECEPTOR (L-ENDOGLIN), TWO ADDITIONAL FORMS OF ENDOGLIN HAVE BEEN RECENTLY REPORTED TO DISPLAY A ROLE IN VASCULAR PATHOLOGY AND HOMEOSTASIS, ON ONE HAND, THE ALTERNATIVELY SPLICED SHORT ISOFORM (S-ENDOGLIN) AND ON THE OTHER HAND, A SOLUBLE ENDOGLIN FORM (SOL-ENDOGLIN) THAT PROBABLY IS PROTEOLYTICALLY CLEAVED FROM MEMBRANE BOUND ENDOGLIN, THE AIM OF THIS PROJECT IS TO ASSESS THE ROLE THAT THE S-ENDOGLIN AND SOL-ENDOGLIN PLAY IN REGULATING ANGIOGENESIS, VASCULAR REMODELING AND VASCULAR TONE, AS WELL AS TO ANALYZE THE MOLECULAR AND CELLULAR MECHANISMS SUPPORTING THESE EFFECTS,